Endocrine therapy in prostate cancer: time for reappraisal of risks, benefits and cost-effectiveness?

Addition of Radiotherapy to Long-Term Androgen Deprivation in Locally Advanced Prostate Cancer: An Open Randomised Phase 3 Trial

(2012) Nicolas Mottet et al.   EUROPEAN UROLOGY

Androgen Deprivation Therapy for Prostate Cancer and Cardiovascular Death

(2012) Robert P. Blankfield   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy

(2012) Howard I. Scher et al.   NEW ENGLAND JOURNAL OF MEDICINE

Androgen deprivation therapy as adjuvant/neoadjuvant to radiotherapy for high-risk localised and locally advanced prostate cancer: recent developments

(2011) H Payne et al.   BRITISH JOURNAL OF CANCER

Androgen Deprivation Therapy and the Risk of Coronary Heart Disease and Heart Failure in Patients with Prostate Cancer

(2011) Elisa Martín-Merino et al.   DRUG SAFETY

EAU Guidelines on Prostate Cancer. Part II: Treatment of Advanced, Relapsing, and Castration-Resistant Prostate Cancer

(2011) Nicolas Mottet et al.   EUROPEAN UROLOGY

Cardiovascular risk in androgen suppression: underappreciated, under-researched and unresolved: Figure 1

(2011) Liam Bourke et al.   HEART

Association of Androgen Deprivation Therapy With Cardiovascular Death in Patients With Prostate Cancer

(2011) Paul L. Nguyen et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

354 LONG TERM RESULTS OF IMMEDIATE VERSUS DEFERRED ANDROGEN DEPRI-VATION IN PATIENTS WITH NO LOCAL TREATMENT FOR T0–4 N0–2 M0 PROSTATE CANCER (EORTC 30891)

(2011) Urs Studer et al.   JOURNAL OF UROLOGY

Short-term neoadjuvant androgen deprivation and radiotherapy for locally advanced prostate cancer: 10-year data from the TROG 96.01 randomised trial

(2011) James W Denham et al.   LANCET ONCOLOGY

Abiraterone and Increased Survival in Metastatic Prostate Cancer

(2011) Johann S. de Bono et al.   NEW ENGLAND JOURNAL OF MEDICINE

Androgen-Deprivation Therapy in Prostate Cancer and Cardiovascular Risk: A Science Advisory From the American Heart Association, American Cancer Society, and American Urological Association: Endorsed by the American Society for Radiation Oncology

(2010) G. N. Levine et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Does Local Treatment of the Prostate in Advanced and/or Lymph Node Metastatic Disease Improve Efficacy of Androgen-Deprivation Therapy? A Systematic Review

(2010) Paul C.M.S. Verhagen et al.   EUROPEAN UROLOGY

Low serum testosterone and increased mortality in men with coronary heart disease

(2010) C. J. Malkin et al.   HEART

Absolute and Relative Risk of Cardiovascular Disease in Men With Prostate Cancer: Results From the Population-Based PCBaSe Sweden

(2010) Mieke Van Hemelrijck et al.   JOURNAL OF CLINICAL ONCOLOGY

External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study

(2010) Michel Bolla et al.   LANCET ONCOLOGY

Reimbursement Policy and Androgen-Deprivation Therapy for Prostate Cancer

(2010) Vahakn B. Shahinian et al.   NEW ENGLAND JOURNAL OF MEDICINE

Impact of the Duration of Adjuvant Hormonal Therapy in Patients With Locally Advanced Prostate Cancer Treated With Radiotherapy: A Secondary Analysis of RTOG 85-31

(2009) Luis Souhami et al.   JOURNAL OF CLINICAL ONCOLOGY

Diabetes and Cardiovascular Disease During Androgen Deprivation Therapy: Observational Study of Veterans With Prostate Cancer

(2009) N. L. Keating et al.   JNCI-Journal of the National Cancer Institute

Early Versus Delayed Endocrine Treatment of T2-T3 pN1-3 M0 Prostate Cancer Without Local Treatment of the Primary Tumour: Final Results of European Organisation for the Research and Treatment of Cancer Protocol 30846 After 13 Years of Follow-up (A Randomised Controlled Trial)

(2008) Fritz H. Schröder et al.   EUROPEAN UROLOGY

Short-Term Neoadjuvant Androgen Deprivation Therapy and External-Beam Radiotherapy for Locally Advanced Prostate Cancer: Long-Term Results of RTOG 8610

(2008) Mack Roach et al.   JOURNAL OF CLINICAL ONCOLOGY

Cardiovascular Mortality After Androgen Deprivation Therapy for Locally Advanced Prostate Cancer: RTOG 85-31

(2008) Jason A. Efstathiou et al.   JOURNAL OF CLINICAL ONCOLOGY

Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial

(2008) Anders Widmark et al.   LANCET